CRL

CHARLES RIVER LABORATORIES INTERNATIONAL INC

Apr 05 • 04:00PM ET

140.97

+2.08 (+1.50%)

Company Profile

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-cl ... read more

Full Time Employees 20,400

Phone 781 222 6000

Website https://www.criver.com

CEO Mr. James C. Foster J.D.

IPO Date 2000-06-23

Sector Healthcare

Industry Medical - Diagnostics & Research

Address 251 Ballardvale Street, Wilmington, MA 01887

Balance Sheet

Total Cash $229,356,000

Total Debt $2,985,865,000

Current Ratio 1.43

Quick Ratio 0.94

Profitability

Gross Margin 32.43%

Net Margin -0.63%

ROE -0.79%

ROA -0.33%

ROIC -2.56%

Balance Sheet

Total Cash $229,356,000

Total Debt $2,985,865,000

Current Ratio 1.43

Quick Ratio 0.94

Profitability

Gross Margin 32.43%

Net Margin -0.63%

ROE -0.79%

ROA -0.33%

ROIC -2.56%

Name	CHARLES RIVER LABORATORIES INTERNATIONAL INC	Sector	Healthcare	Currency	USD	Relative Volume	1.4	Market Cap	7001
Current Ratio	1.41	Dividend / Share	0.0	EPS	0.2	Revenue	4049989000	P/S	1.7
P/E	679.9	Beta	1.13	Income	22203000	Volume	1666009	Average Volume	1188184
Distance to 200DMA	-27.81%	200 DMA	189.65	50 DMA	162.69	ROA	0.1	ROE	0.3
Distance to 50DMA	-15.85%	Return 1Y	-47.21%	Return YTD	-25.84%	Forward PE		Qtly Growth YOY
Debt/Eq	1.16	P/B	2.0	Dividend Yield	0.0%	Net Margin	0.55%	Payout Ratio	0.0

Performance

52 Week Range 0.0%

Distance to 200DMA 0.0%

Day Change Percent $0.00

Performance Range

Day

$196

Current

Low: High:

Month

$196

Current

Low: High:

Month

$196

Current

Low: High:

Month

$196

Current

Low: High:

Month

$196

Current

Low: High:

Balance Sheet

Total Cash $210,171,000

Total Debt $2,759,489,000

Current Ratio 1.48%

Quick Ratio 0.95%

Profitability

Valuation

Price to Earnings -282.50

Price to Book 2.24

Price to Sales 1.78

Price to Free Cash Flow 12.68

Dividends

Payout Ratio -0.00%

Dividend Yield 0.00%

Dividend Amount $0.00

Performance

52 Week Range 0.0%

Distance to 200DMA 0.0%

Day Change Percent $0.00

Company Profile

Full Time Employees 20,400

Phone 781 222 6000

Website https://www.criver.com

CEO Mr. James C. Foster J.D.

IPO Date 2000-06-23

Sector Healthcare

Address 251 Ballardvale Street, Wilmington, MA 01887

Histogram - Daily

Balance Sheet

Total Cash $210,171,000

Total Debt $2,759,489,000

Current Ratio 1.48%

Quick Ratio 0.95%

Profitability

Gross Margin 0.3480%

Net Margin 0.1020%

ROE 0.11%

ROA 0.05%

Company Profile

Full Time Employees 20,400

Phone 781 222 6000

Website https://www.criver.com

CEO Mr. James C. Foster J.D.

IPO Date 2000-06-23

Sector Healthcare

Address 251 Ballardvale Street, Wilmington, MA 01887

Monthly Win Rate

Balance Sheet (Multi-Column Example)

	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Cash & Short Term Investments	53,775.0	65,171.0	61,801.0	67,150.0	73,100.0	61,555.0	62,482.0	55,872.0
Receivables	59,306.0	66,243.0	43,172.0	41,150.0	50,102.0	60,985.0	39,186.0	35,899.0
Inventory	6,911.0	7,286.0	6,165.0	6,232.0	6,511.0	6,331.0	7,351.0	7,482.0

Latest News

Understanding Charles River (CRL) Reliance on International Revenue

Examine Charles River's (CRL) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

2025-05-13 10:21:16 - zacks.com

Charles River Laboratories to Present at Bank of America Health Care Conference

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Bank of America Health Care Conference.

2025-05-13 08:00:00 - businesswire.com

Activist Elliott reaches key agreement with Charles River. Here are three ways t

The firm has three possible paths toward value creation at the drug development company.

2025-05-10 08:49:33 - cnbc.com

Live Nasdaq Composite: Markets Rise on Fed Day Amid Trade Deal Hopes

Live Updates Live Coverage Has Ended GOOGL Falls 9% 2:51 pm by Gerelyn Terzo Google parent Alphabet (Nasdaq: GOOGL) stock is down a steep 9% to below $150 per share today after an Apple (Nasdaq; AAPL)

2025-05-08 13:00:11 - https://247wallst.com

S&P 500 INDEX (SPX) Live: Markets Eye Potential Bullish Trend as Buying Resumes

Live Updates Live Coverage Has Ended Rates Unchanged, Stagflation Looms 2:20 pm by Gerelyn Terzo The Dow has reversed a deficit, turning a 200-point drop to a 27-point gain after the Federal Reserve k

2025-05-08 13:00:11 - https://247wallst.com

S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React t

The S&P 500 broke a two-session losing streak, rising Wednesday as stocks gained ground in volatile trading following the Federal Reserve's decision to keep interest rates unchanged.

2025-05-07 17:31:19 - investopedia.com

Charles River Laboratories International, Inc. (CRL) Q1 2025 Earnings Call Trans

Charles River Laboratories International, Inc. (NYSE:CRL ) Q1 2025 Results Conference Call May 7, 2025 9:00 AM ET Company Participants Todd Spencer - Vice President, Investor Relations Jim Foster - Ch

2025-05-07 14:46:13 - seekingalpha.com

Charles River Laboratories' Q1 Earnings Beat Consensus, Stock Trades Higher On S

Charles River Laboratories International Inc CRL stock is trading higher on Wednesday after the company released better than expected first-quarter 2025 earnings.

2025-05-07 12:39:29 - benzinga.com

Charles River Stock Is Having Its Best Day in 13 Years. A Board Shake-Up and Bus

The biotech said its largest investor would conduct a ‘strategic review' as revenue continued to decline.

2025-05-07 12:17:00 - barrons.com

Top Stock Moves Now: Charles River Labs, Disney, Supermicro, and More

U.S. equities were little changed at midday as the market awaited the Federal Reserve's interest-rate decision coming this afternoon. The Dow Jones Industrial Average was higher, the Nasdaq was lower,

2025-05-07 11:56:00 - investopedia.com

Compared to Estimates, Charles River (CRL) Q1 Earnings: A Look at Key Metrics

The headline numbers for Charles River (CRL) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street est

2025-05-07 10:35:55 - zacks.com

CRL Q1 Earnings & Revenues Beat Estimates, Stock Rises, '25 View Up

Charles River delivers better-than-expected earnings and revenues in the first quarter of 2025.

2025-05-07 10:35:33 - zacks.com

Charles River Laboratories (CRL) Beats Q1 Earnings and Revenue Estimates

Charles River Laboratories (CRL) came out with quarterly earnings of $2.34 per share, beating the Zacks Consensus Estimate of $2.06 per share. This compares to earnings of $2.27 per share a year ago.

2025-05-07 09:15:42 - zacks.com

Charles River to add new directors, review business in agreement with Elliott

Charles River Laboratories said on Wednesday it had reached an agreement with activist investor Elliott Investment Management and added four new directors to its board.

2025-05-07 07:35:24 - reuters.com

Charles River Laboratories Announces First-Quarter 2025 Results

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Announces First-Quarter 2025 Financial Results.

2025-05-07 07:01:00 - businesswire.com

Charles River Laboratories Announces Governance Updates and Strategic Review to

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value.

2025-05-07 07:00:00 - businesswire.com